Protecting Life
We Work to Deliver Vaccines that can Protect Millions Around MENA Region.
2005
Established
Arabio was established as a leading vaccine manufacturer in GCC region.
2006
Strategic Partners
New strategic partners have joined Arabio to support company's efforts and to access other Arabian markets.
2009
Facility Completion
Arabio facility civil work completion.
2010
Entered the Vaccine Market
Arabio has signed a first license agreement with Novartis vaccines to manufacture & promote its vaccines in MENA region.
2011
First Launch in Saudi Private Market
Aramen Meningococcal conjugate ACWY vaccine.
2012
Expanded in Vaccine Business
Arabio has signed a license agreement with InterVax to manufacture & promote its vaccines in MENA region.
2013
Entered Biological Market
Arabio has signed toll manufacture agreement with Abbvie to locally manufacture its biological products.
2014
Continued Expansion in Vaccine Market
Arabio has signed toll manufacture agreement with GSK Vaccines to manufacture all GSK liquid vaccine.
2015
Strengthened our Position in Vaccine & Biological Markets:
Arabio has signed a license agreement with BioFarma to manufacture & promote its WHO prequalified vaccines in MENA region.
Arabio has signed toll manufacture agreement with Janssen to locally manufacture its biological products.
